170489 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
Sub-classes:EXAMINATION METHOD FOR IMMUNE-RELATED ADVERSE EVENT ENTERITIS
#2KIT FOR DIAGNOSING ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE
#3BIOMARKERS
#4BLOOD BIOMARKERS IN LONG-COVID-19
#5VEGF MUTANTS AND MODULATION OF INTEGRIN-MEDIATED SIGNALING
#6POLYNUCLEOTIDES ENCODING INTEGRIN BETA-6 AND METHODS OF USE THEREOF
#7METHODS AND PRODUCTS FOR EVALUATING AN IMMUNE RESPONSE TO A THERAPEUTIC PROTEIN
#8Marker for Neural Stem Cells
#9USE OF A FUC-ALPHA(1-2)-GAL GLYCAN STRUCTURE AS A BIOMARKER FOR BLADDER CANCER
#10VEDOLIZUMAB FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE
#11DETECTION AND QUANTIFICATION OF NATALIZUMAB
#12INDIRECT HOMOGENEOUS MOBILITY SHIFT ASSAYS FOR THE DETECTION OF BIOLOGICS IN PATIENT SAMPLES
#13DETECTION OF BIOMARKERS USEFUL IN DIAGNOSING CHRONIC ENTEROPATHIES IN CATS
#14DETECTION AND QUANTIFICATION OF NATALIZUMAB
#15MULTI-PROTEIN CLASSIFIER FOR DETECTING EARLY-STAGE OVARIAN CANCER
#16FOCAL ADHESION COMPLEX PROTEINS AS A DIAGNOSTIC MARKER FOR PODOCYTOPHATHIES
#17Quality assurance of chondrocytes
#18Antibodies Directed Against CD127
#19COMPOSITIONS AND METHODS FOR TREATMENT
#20USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#21ANTI-VLA-4 RELATED ASSAYS
#22METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS
#23METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS
#24TEST METHOD FOR ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
#25BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS
#26METHODS OF DETECTING MARKERS FOR INFLAMMATORY CONDITIONS AND FOOD SENSITIVITY IN COMPANION ANIMALS
#27Detection and Treatment of Malignant Tumours in the CNS
#28Detection and quantification of natalizumab
#29ICOSL for use as a Renal Therapeutic
#30Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors
#31METHODS FOR PREVENTING AND/OR TREATING BONE LOSS CONDITIONS BY MODULATING IRISIN
#32Methods and products for evaluating an immune response to a therapeutic protein
#33Quality assurance of chondrocytes
#34IgG epitope and applications thereof as a drug target
#35BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS
#36METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO GERM CELLS
#37DIAGNOSTIC MARKERS OF COGNITIVE IMPAIRMENTS, KITS AND USES THEREOF
#38Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#39Anti-VLA-4 related assays
#40Vedolizumab for the treatment of fistulizing Crohn's disease
#41USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#42Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody
#43Marker for Neural Stem Cells
#44Quality assurance of chondrocytes
#45COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#46Methods for diagnosing and treating inflammatory bowel disease
#47PEPTIDES WITH ANTI-ANGIOGENIC, ANTI-LYMPHANGIOGENIC, AND ANTI-EDEMIC PROPERTIES AND NANOPARTICLE FORMULATIONS
#48Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#49Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#50COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#51Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation
#52Detection and treatment of malignant tumours in the CNS
#53Method for inducing differentiation of pluripotent stem cells into germ cells
#54INTERGRIN ALPHA V BETA 6 FOR DIAGNOSIS/PROGNOSIS OF COLORECTAL CARCINOMA
#55Anti-VLA-4 related assays
#56Diagnostic markers of cognitive impairments, kits and uses thereof
#57Methods and products for evaluating an immune response to a therapeutic protein
#58METHODS OF DETECTING INFLAMMATORY MARKERS AND TREATING INFLAMMATORY CONDITIONS IN HUMANS
#59Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#60Detection of activated monocytes in human peripheral blood and determining the concentration of cell surface integrin using plasmon amplified raman detection
#61Vedolizumab for the Treatment of Fistulizing Crohn's Disease
#62Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease
#63Multivalent fibronectin-integrin binding compositions and methods of use thereof
#64COMPOSITIONS AND METHODS FOR AUTOIMMUNE DISEASE
#65COMPOSITIONS AND METHODS FOR TREATMENT
#66COMPOSITIONS AND METHODS FOR TREATMENT
#67Antibodies directed against CD127
#68USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#69Antibodies to MAdCAM
#70Methods for determining differences in alpha-4 integrin activity by correlating differences in sVCAM and/or sMAdCAM levels
#71Anti-VLA-4 related assays
#72USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#73METHODS FOR DIAGNOSING AND TREATING IMMUNE DISEASE
#74Integrin αvβ8 neutralizing antibody
#75Detection of gluten-specific t-cells
#76METHODS FOR DIAGNOSIS OF CELIAC DISEASE
#77INTERGRIN ALPHA V BETA 6 FOR DIAGNOSIS/PROGNOSIS OF COLORECTAL CARCINOMA
#78Methods for diagnosing and treating inflammatory bowel disease
#79PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS
#80ISOLATION AND CHARACTERIZATION OF MUSCLE REGENERATING CELLS
#81Anti-αβantibodies
#82COMPOSITIONS AND METHODS FOR TREATMENT
#83COMPOSITIONS AND METHODS FOR TREATMENT
#84COMPOSITIONS AND METHODS FOR TREATMENT
#85COMPOSITIONS AND METHODS FOR TREATMENT
#86COMPOSITIONS AND METHODS FOR TREATMENT
#87Methods and products for evaluating an immune response to a therapeutic protein
#88COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#89Biomarkers for Tuberculosis and HIV/AIDS
#90Administration of alpha4beta7 hetero-dimer-specific antibody
#91Markers for susceptibility to an inhibitor of an Src-family kinase
#92Cystine knot peptides that bind alpha-V-beta-6 integrin
#93Compositions and methods for treatment
#94Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
#95Antibodies for the detection of integrin complexes in FFPE material
#96Bladder cancer tumor marker, antibody and use thereof
#97Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the same
#98Specific binding sites in collagen for integrins and use thereof
#99Anti-human α9 integrin antibody and use thereof
#100Integrin α-Vβ8 neutralizing antibody
#101Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR)
#102Method for integrin ligand discovery
#103Anti-VLA-4 related assays
#104ANTI-ALPHA V BETA 6 ANTIBODIES
#105Compositions and methods for treatment of eye disorders
#106IMMUNOREGULATION IN CANCER, CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
#107SPECIFIC BINDING SITES IN COLLAGEN FOR INTEGRINS AND USE THEREOF
#108Methods and products for evaluating an immune response to a therapeutic protein
#109Antibodies for the detection of integrin complexes in FFPE material
#110Insulin-like growth factor signaling and integrin
#111ANTI- INTEGRIN ANTIBODIES, COMPOSITIONS, METHODS AND USES
#112Anti-human α9 integrin antibody and use thereof
#113Anti-αβantibodies and uses thereof
#114PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS
#115Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
#116NEUREGULIN/ERBB SIGNALING AND INTEGRIN
#117Compositions and methods for treatment
#118Compositions and methods for treatment
#119Marker for stem cells and its use
#120PRESENT INVENTION RELATES TO METHODS FOR PREDICTION OF THE THERAPEUTIC SUCCESS OF BREAST CANCER THERAPY
#121Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
#122PROTEIN
#123USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#124Diagnosis and monitoring of renal failure using peptide biomarkers
#125DIAGNOSTIC SUBSTANCE AND METHOD FOR THE DIAGNOSIS OF PROSTATE DISEASES
#126Stabilized low affinity conformation of integrins for drug discovery
#127OSTEOPONTIN FUNCTIONAL EPITOPES, MONOCLONAL ANTIBODIES AGAINST THE EPITOPES AND USES THEREOF
#128Compositions and methods for treatment of eye disorders
#129COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#130METHOD OF EVALUATING ANTIWRINKLE SUBSTANCE AND METHOD OF ASSESSING THE SKIN
#131Cyclopeptides containing RGD mimetics as imaging markers for integrins
#132Tumor homing molecules, conjugates derived therefrom, and methods of using same
#133Tumor homing molecules, conjugates derived therefrom, and methods of using same
#134NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same
#135Antihuman α9 integrin antibody and use of the same
#136Anti-integrin antibodies, compositions, methods and uses
#137Specific binding sites in collagen for integrins and use thereof
#138Anti-integrin antibodies, compositions, methods and uses
#139Anti-αβantibodies
#140Peptides and methods for the treatment of inflammatory disease
#141Methods and products for evaluating an immune response to a therapeutic protein
#142Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents
#143Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
#144INTEGRIN ALPHA 7 MUTATIONS IN PROSTATE CANCER, LIVER CANCER, GLIOBLASTOMA MULTIFORME, AND LEIOMYOSARCOMA
#145Anti-αβantibodies and uses thereof
#146Genes Associated With Type ll Diabetes Mellitus
#147Anti-α9 integrin antibody and the use thereof
#148Antibodies to MAdCAM
#149Integrin-linked kinase and its uses
#150Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
#151High-throughput screening method for intergrin antagonist and new peptide screened therefrom
#152Integrin-linked kinase and its uses
#153Method for identifying an anti- streptococcal agent and its use for treating streptococcal infections
#154Antibodies to MAdCAM
#155Anti-integrin antibodies, compositions, methods and uses
#156Accessing predictive data for determining a range of possible outcomes of treatment
#157Specific binding sites in collagen for integrins and use thereof
#158In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto
#159Accessing data related to tissue coding
#160Data techniques related to tissue coding
#161Search techniques related to tissue coding
#162Data techniques related to tissue coding
#163Filtering predictive data
#164Data accessing techniques related to tissue coding
#165Accessing data related to tissue coding
#166Accessing data related to tissue coding
#1673-structure of a whole integrin $g(a) v$g(b) extracellular region and uses therefor
#168Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
#169Compositions and methods for treatment of eye disorders
#170Methods of screening for anti-inflammatory drugs and use thereof
#171Assay method
#172Protein scaffolds and uses thereof
#173Methods of identifying and designing cell surface receptor inhibitors
#174Anti-αβantibodies
#175Assay method
#176Human antibodies that bind human MAdCAM
#177Marker for stem cells and its use
#178Methods for inhibiting angiogenesis
#179Assay